Adjudicated Outcomes
| File Name | Data as of | Population | Data collected | One row per | Rows |
|---|---|---|---|---|---|
| outc_ct_os_inv.dat | 2/17/2024 | CT+OS | Main, Ext1, Ext2 | Participant | 161,808 |
ID - WHI Participant Common ID Col 1
ANGINA - Angina Col 2 Usage Notes: Angina was adjudicated for CT and OS participants during the core WHI study. Angina occurring on or after a Clinical MI is not counted.
ANGINADY - Days enrollment to Angina Col 3 Days enrollment to Angina
ANGINASRC - Angina ascertainment source Col 4 Usage Notes: Angina was only adjudicated locally.
AANEUR - Aortic Aneurysm Col 5 Usage Notes: Started collecting this outcome in Ext2. It is only adjudicated for the Medical Record Cohort.
AANEURDY - Days enrollment to Aortic Aneurysm Col 6 Days enrollment to Aortic Aneurysm
AANEURSRC - Aortic Aneurysm ascertainment source Col 7
ADISSECT - Aortic Dissection Col 8 Usage Notes: Started collecting this outcome in Ext2. It is only adjudicated for the Medical Record Cohort.
ADISSECTDY - Days enrollment to Aortic Dissection Col 9 Days enrollment to Aortic Dissection
ADISSECTSRC - Aortic Dissection ascertainment source Col 10
CABG - CABG Col 11 Coronary Artery Bypass Graft (CABG) Usage Notes: CABG was adjudicated for CT and OS participants through Ext1. In Ext2 it is only adjudicated for the Medical Record Cohort.
CABGDY - Days enrollment to CABG Col 12 Days enrollment to CABG
CABGSRC - CABG ascertainment source Col 13 Usage Notes: During the core WHI study, only local adjudications were done for CABG. After the WHI study closeout, all adjudications are done centrally.
CAROTID - Carotid Artery Disease Col 14 Usage Notes: Carotid Artery Disease was adjudicated for CT and OS participants through Ext1. In Ext2 It is only adjudicated for the Medical Record Cohort. Carotid Artery Disease occurring on or after a Stroke is not counted.
CAROTIDDY - Days enrollment to Carotid Artery Disease Col 15 Days enrollment to Carotid Artery Disease
CAROTIDSRC - Carotid Artery Disease ascertainment source Col 16 Usage Notes: During the core WHI study, only local adjudications were done for Carotid Artery Disease. After the WHI study closeout, all adjudications are done centrally.
CHD - CHD Col 17 Coronary Heart Disease (CHD) Usage Notes: Defined as the first occurrence of Clinical MI, Definite Silent MI or a Death due to Definite CHD or Possible CHD. Clinical MI and Death were adjudicated for CT and OS ppts through Ext1. In Ext2 they are only adjudicated for the Medical Record Cohort. Definite Silent MI was only adjudicated for CT participants during the core WHI study. See the DEATH and DEATHSRC variables for details about the death adjudication process.
CHDDY - Days enrollment to CHD Col 18 Days enrollment to CHD
CHDSRC - CHD ascertainment source Col 19 Usage Notes: The ascertainment processes vary for these outcomes. Refer to their usage notes. See the DEATH and DEATHSRC variables for details about the death adjudication process.
CHF - CHF Col 20 Congestive Heart Failure (CHF) Usage Notes: CHF was adjudicated for CT and OS participants during the core WHI study.
CHFDY - Days enrollment to CHF Col 21 Days enrollment to CHF
CHFSRC - CHF ascertainment source Col 22 Usage Notes: CHF was only adjudicated locally.
MI - Clinical MI Col 23 Usage Notes: Clinical MI was adjudicated for CT and OS participants through Ext1. In Ext2 it is only adjudicated for the Medical Record Cohort.
MIDY - Days enrollment to Clinical MI Col 24 Days enrollment to Clinical MI
MISRC - Clinical MI ascertainment source Col 25 Usage Notes: During the core WHI study, central adjudications of Clinical MI were only done for HT participants. After the WHI study closeout, all adjudications are done centrally.
CREVASC - Coronary Revascularization Col 26 Coronary revascularization procedure (CABG or PTCA) Usage Notes: Defined as the first occurrence of CABG or PTCA. Coronary Revascularization was adjudicated for CT and OS participants through Ext1. In Ext2 it is only adjudicated for the Medical Record Cohort.
CREVASCDY - Days enrollment to Coronary Revascularization Col 27 Days enrollment to Coronary Revascularization
CREVASCSRC - Coronary Revascularization ascertainment source Col 28 Usage Notes: During the core WHI study, only local adjudications were done for Coronary Revascularization. After the WHI study closeout, all adjudications are done centrally.
DSMI - Definite Silent MI Col 29 Usage Notes: Defined as an ECG with an evolving Q-wave MI based on an incident Novacode of 5.1 or 5.2. ECGs were adjudicated for CT participants at baseline, av3, av6 and av9. Definite Silent MI occurring on or after a Clinical MI is not counted.
DSMIDY - Days enrollment to Definite Silent MI Col 30 Days enrollment to Definite Silent MI
DSMISRC - Definite Silent MI ascertainment source Col 31
DVT - DVT Col 32 Deep Vein Thrombosis (DVT) Usage Notes: DVT is adjudicated for the Medical Record Super Cohort through Ext1. In Ext2 it is adjudicated for the Medical Record Cohort. Includes both outpatient and inpatient DVTs.
DVTDY - Days enrollment to DVT Col 33 Days enrollment to DVT
DVTSRC - DVT ascertainment source Col 34 Usage Notes: During the core WHI study, central adjudications of DVT were only done for HT participants. After the WHI study closeout, all adjudications are done centrally.
HEARTVALVE - Heart Valve Disease Col 35 Moderate to severe valvular disease involving one or more valves Usage Notes: Started collecting this outcome in Ext2. It is only adjudicated for the Medical Record Cohort.
HEARTVALVEDY - Days enrollment to Heart Valve Disease Col 36 Days enrollment to Heart Valve Disease
HEARTVALVESRC - Heart Valve Disease ascertainment source Col 37
STRKHEMO - Hemorrhagic Stroke Col 38 Usage Notes: Defined as a Stroke where the diagnosis question indicates a hemorrhagic stroke. Hemorrhagic Stroke was adjudicated for CT and OS participants through Ext1. In Ext2 it is only adjudicated for the Medical Record Cohort. Strokes from cause of death, Form 121 and early versions of 132 were not able to determine Hemorrhagic/Ischemic classification. Includes inpatient strokes for the core WHI study and inpatient and outpatient strokes after the core study closeout.
STRKHEMODY - Days enrollment to Hemorrhagic Stroke Col 39 Days enrollment to Hemorrhagic Stroke
STRKHEMOSRC - Hemorrhagic Stroke ascertainment source Col 40 Usage Notes: In order to be able to classify strokes, WHI uses central adjudications if possible, even though during the core WHI study Strokes were only fully centrally adjudicated in HT participants.
STRKISCH - Ischemic Stroke Col 41 Usage Notes: Defined as a Stroke where the diagnosis question indicates an iscemic stroke. Ischemic Stroke was adjudicated for CT and OS participants through Ext1. In Ext2 it is only adjudicated for the Medical Record Cohort. Strokes from cause of death, Form 121 and early versions of 132 were not able to determine Hemorrhagic/Ischemic classification. Includes inpatient strokes for the core WHI study and inpatient and outpatient strokes after the core study closeout.
STRKISCHDY - Days enrollment to Ischemic Stroke Col 42 Days enrollment to Ischemic Stroke
STRKISCHSRC - Ischemic Stroke ascertainment source Col 43 Usage Notes: In order to be able to classify strokes, WHI uses central adjudications if possible, even though during the core WHI study Strokes were only fully centrally adjudicated in HT participants.
PERIPH - PAD Col 44 Peripheral Arterial Disease (PAD) Usage Notes: PAD was adjudicated for CT and OS participants through Ext1. In Ext2 it is only adjudicated for the Medical Record Cohort.
PERIPHDY - Days enrollment to PAD Col 45 Days enrollment to PAD
PERIPHSRC - PAD ascertainment source Col 46 Usage Notes: During the core WHI study, only local adjudications were done for PAD. After the WHI study closeout, all adjudications are done centrally.
PE - PE Col 47 Pulmonary Embolism (PE) Usage Notes: Defined as the first occurrence of PE or a Death due to Pulmonary Embolism. PE was adjudicated for the Medical Record Super Cohort through Ext1. In Ext2 it is adjudicated for the Medical Record Cohort. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PEDY - Days enrollment to PE Col 48 Days enrollment to PE
PESRC - PE ascertainment source Col 49 Usage Notes: Central adjudications were done for PE. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PSMI - Possible Silent MI Col 50 Usage Notes: Defined as an ECG with an evolving Q-wave MI based on an incident Novacode of 5.3 or 5.4. ECGs were adjudicated for CT participants at baseline, av3, av6 and av9. Possible Silent MI occurring on or after a Clinical MI or Definite Silent MI is not counted.
PSMIDY - Days enrollment to Possible Silent MI Col 51 Days enrollment to Possible Silent MI
PSMISRC - Possible Silent MI ascertainment source Col 52
PTCA - PTCA Col 53 Percutaneous Transluminal Coronary Angioplasty (PTCA) Usage Notes: PTCA was adjudicated for CT and OS participants through Ext1. In Ext2 it is only adjudicated for the Medical Record Cohort. Includes both outpatient and inpatient PTCAs
PTCADY - Days enrollment to PTCA Col 54 Days enrollment to PTCA
PTCASRC - PTCA ascertainment source Col 55 Usage Notes: During the core WHI study, only local adjudications were done for PTCA. After the WHI study closeout, all adjudications are done centrally.
STROKE - Stroke Col 56 Usage Notes: Defined as the first occurrence of Stroke or a Death due to Cerebrovascular. Stroke was adjudicated for CT and OS participants through Ext1. In Ext2 it is only adjudicated for the Medical Record Cohort. In order to be able to classify strokes, WHI uses central adjudications if possible, even though Strokes were only fully centrally adjudicated in HT participants. See the DEATH and DEATHSRC variables for details about the death adjudication process. Includes inpatient strokes for the core WHI study and inpatient and outpatient strokes after the core study closeout.
STROKEDY - Days enrollment to Stroke Col 57 Days enrollment to Stroke
STROKESRC - Stroke ascertainment source Col 58 Usage Notes: In order to be able to classify strokes, WHI uses central adjudications if possible, even though during the core WHI study Strokes were only fully centrally adjudicated in HT participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
TIA - TIA Col 59 Transient Ischemic Attack (TIA) Usage Notes: TIA was adjudicated for CT and OS participants during the core WHI study. TIA occurring on or after a Stroke is not counted.
TIADY - Days enrollment to TIA Col 60 Days enrollment to TIA
TIASRC - TIA ascertainment source Col 61 Usage Notes: During the core WHI study, central adjudications of TIA were only done for HT participants.
MITOTAL - Total MI Col 62 Usage Notes: Defined as: For CT, the first occurrence of Clinical MI or Definite Silent MI. For OS, the first Clinical MI only.
MITOTALDY - Days enrollment to Total MI Col 63 Days enrollment to Total MI
MITOTALSRC - Total MI ascertainment source Col 64 Usage Notes: The ascertainment processes vary for these outcomes. Refer to their usage notes.
ANYCANCER - Any Cancer Col 65 Usage Notes: Defined as the first occurrence of any cancer (except non melanoma skin cancer) or a Death due to cancer. Any Cancer is adjudicated for CT and OS participants.
ANYCANCERDY - Days enrollment to Any Cancer Col 66 Days enrollment to Any Cancer
ANYCANCERSRC - Any Cancer ascertainment source Col 67 Usage Notes: Central adjudications were done for Any Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
SINUS - Accessory Sinus Cancer Col 68 Usage Notes: Defined as the first occurrence of Accessory Sinus Cancer or a Death due to Accessory Sinus Cancer. Accessory Sinus Cancer is adjudicated for CT and OS participants.
SINUSDY - Days enrollment to Accessory Sinus Cancer Col 69 Days enrollment to Accessory Sinus Cancer
SINUSSRC - Accessory Sinus Cancer ascertainment source Col 70 Usage Notes: Central adjudications were done for Accessory Sinus Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ADRENAL - Adrenal Gland Cancer Col 71 Usage Notes: Defined as the first occurrence of Adrenal Gland Cancer or a Death due to Adrenal Gland Cancer. Adrenal Gland Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ADRENALDY - Days enrollment to Adrenal Gland Cancer Col 72 Days enrollment to Adrenal Gland Cancer
ADRENALSRC - Adrenal Gland Cancer ascertainment source Col 73 Usage Notes: Central adjudications were done for Adrenal Gland Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ANAL - Anus Cancer Col 74 Usage Notes: Defined as the first occurrence of Anus Cancer or a Death due to Anus Cancer. Anus Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ANALDY - Days enrollment to Anus Cancer Col 75 Days enrollment to Anus Cancer
ANALSRC - Anus Cancer ascertainment source Col 76 Usage Notes: Central adjudications were done for Anus Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
APPENDIX - Appendix Cancer Col 77 Usage Notes: Defined as the first occurrence of Appendix Cancer or a Death due to Appendix Cancer. Appendix Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
APPENDIXDY - Days enrollment to Appendix Cancer Col 78 Days enrollment to Appendix Cancer
APPENDIXSRC - Appendix Cancer ascertainment source Col 79 Usage Notes: Central adjudications were done for Appendix Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BASETONGUE - Base Of Tongue Cancer Col 80 Usage Notes: Defined as the first occurrence of Base Of Tongue Cancer or a Death due to Base Of Tongue Cancer. Base Of Tongue Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BASETONGUEDY - Days enrollment to Base Of Tongue Cancer Col 81 Days enrollment to Base Of Tongue Cancer
BASETONGUESRC - Base Of Tongue Cancer ascertainment source Col 82 Usage Notes: Central adjudications were done for Base Of Tongue Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BILIARY - Biliary Tract Cancer Col 83 Usage Notes: Defined as the first occurrence of Biliary Tract Cancer or a Death due to Biliary Tract Cancer. Biliary Tract Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BILIARYDY - Days enrollment to Biliary Tract Cancer Col 84 Days enrollment to Biliary Tract Cancer
BILIARYSRC - Biliary Tract Cancer ascertainment source Col 85 Usage Notes: Central adjudications were done for Biliary Tract Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BLADDER - Bladder Cancer Col 86 Usage Notes: Defined as the first occurrence of Bladder Cancer or a Death due to Bladder Cancer. Bladder Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BLADDERDY - Days enrollment to Bladder Cancer Col 87 Days enrollment to Bladder Cancer
BLADDERSRC - Bladder Cancer ascertainment source Col 88 Usage Notes: Central adjudications were done for Bladder Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BONELIMB - Bone-Limb Cancer Col 89 Cancer of the bones, joints or cartilage of limbs (long bones) Usage Notes: Defined as the first occurrence of Bone-Limb Cancer or a Death due to Bone-Limb Cancer. Bone-Limb Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BONELIMBDY - Days enrollment to Bone-Limb Cancer Col 90 Days enrollment to Bone-Limb Cancer
BONELIMBSRC - Bone-Limb Cancer ascertainment source Col 91 Usage Notes: Central adjudications were done for Bone-Limb Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BONENON - Bone-Non Limb Cancer Col 92 Cancer of the bones, joints or cartilage of non-limbs (face, head, torso, spine). Usage Notes: Defined as the first occurrence of Bone-Non Limb Cancer or a Death due to Bone-Non Limb Cancer. Bone-Non Limb Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BONENONDY - Days enrollment to Bone-Non Limb Cancer Col 93 Days enrollment to Bone-Non Limb Cancer
BONENONSRC - Bone-Non Limb Cancer ascertainment source Col 94 Usage Notes: Central adjudications were done for Bone-Non Limb Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BRAIN - Brain Cancer Col 95 Usage Notes: Defined as the first occurrence of Brain Cancer or a Death due to Brain Cancer. Brain Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BRAINDY - Days enrollment to Brain Cancer Col 96 Days enrollment to Brain Cancer
BRAINSRC - Brain Cancer ascertainment source Col 97 Usage Notes: Central adjudications were done for Brain Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BREAST - Breast Cancer Col 98 Usage Notes: Defined as the first occurrence of Invasive or In Situ Breast Cancer. All Deaths due to breast cancer are considered Invasive Breast Cancers. Breast Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BREASTDY - Days enrollment to Breast Cancer Col 99 Days enrollment to Breast Cancer
BREASTSRC - Breast Cancer ascertainment source Col 100 Usage Notes: Central adjudications were done for Breast Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BREASTINV - Breast Cancer Invasive Col 101 Usage Notes: Defined as a breast cancer from a Death or the first adjudication where the form 122 or 130 details indicate an invasive cancer. Breast Cancer Invasive is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process. WHI adjudicated all reports of breast cancer for a ppt until the first invasive Breast Cancer. i.e. The first Invasive Breast Cancer may not be the first Breast Cancer.
BREASTINVDY - Days enrollment to Breast Cancer Invasive Col 102 Days enrollment to Breast Cancer Invasive
BREASTINVSRC - Breast Cancer Invasive ascertainment source Col 103 Usage Notes: Central adjudications were done for Breast Cancer Invasive. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
BREASTINSITU - Breast Cancer In Situ Col 104 Usage Notes: Defined as the first breast cancer where the form 122 or 130 details indicate an in situ cancer. Breast Cancer In Situ is adjudicated for CT and OS participants. Breast Cancer In Situ occurring on or after a Breast Cancer Invasive is not counted.
BREASTINSITUDY - Days enrollment to Breast Cancer In Situ Col 105 Days from enrollment to first Breast Cancer In Situ
BREASTINSITUSRC - Breast Cancer In Situ ascertainment source Col 106 Usage Notes: Central adjudications were done for all Breast Cancer In Situ. If the central adjudication is not complete, local adjudication data is used.
CNSCA - Central Nervous System Cancer Col 107 Cancer of central nervous system (not brain) Usage Notes: Defined as the first occurrence of Central Nervous System Cancer or a Death due to Central Nervous System Cancer. Central Nervous System Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
CNSCADY - Days enrollment to Central Nervous System Cancer Col 108 Days enrollment to Central Nervous System Cancer
CNSCASRC - Central Nervous System Cancer ascertainment source Col 109 Usage Notes: Central adjudications were done for Central Nervous System Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
CERVICAL - Cervix Cancer Col 110 Usage Notes: Defined as the first occurrence of Cervix Cancer or a Death due to Cervix Cancer. Cervix Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
CERVICALDY - Days enrollment to Cervix Cancer Col 111 Days enrollment to Cervix Cancer
CERVICALSRC - Cervix Cancer ascertainment source Col 112 Usage Notes: Central adjudications were done for Cervix Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
COLON - Colon Cancer Col 113 Usage Notes: Defined as the first occurrence of Colon Cancer or a Death due to Colon Cancer. Colon Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
COLONDY - Days enrollment to Colon Cancer Col 114 Days enrollment to Colon Cancer
COLONSRC - Colon Cancer ascertainment source Col 115 Usage Notes: Central adjudications were done for Colon Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
COLORECTAL - Colorectal Cancer Col 116 Usage Notes: Defined as the first occurrence of Colon Cancer, Rectosigmoid Cancer, Rectum Cancer or a Death due to Colon Cancer, Rectum Cancer or Rectosigmoid Cancer. Colorectal Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
COLORECTALDY - Days enrollment to Colorectal Cancer Col 117 Days enrollment to Colorectal Cancer
COLORECTALSRC - Colorectal Cancer ascertainment source Col 118 Usage Notes: Central adjudications were done for Colorectal Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
CONNECTIVE - Connective Tissue Cancer Col 119 Cancer of connective, subcutaneous and soft tissues Usage Notes: Defined as the first occurrence of Connective Tissue Cancer or a Death due to Connective Tissue Cancer. Connective Tissue Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
CONNECTIVEDY - Days enrollment to Connective Tissue Cancer Col 120 Days enrollment to Connective Tissue Cancer
CONNECTIVESRC - Connective Tissue Cancer ascertainment source Col 121 Usage Notes: Central adjudications were done for Connective Tissue Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ENDOCRINE - Endocrine Glands Cancer Col 122 Cancer of endocrine glands and related structures Usage Notes: Defined as the first occurrence of Endocrine Glands Cancer or a Death due to Endocrine Glands Cancer. Endocrine Glands Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ENDOCRINEDY - Days enrollment to Endocrine Glands Cancer Col 123 Days enrollment to Endocrine Glands Cancer
ENDOCRINESRC - Endocrine Glands Cancer ascertainment source Col 124 Usage Notes: Central adjudications were done for Endocrine Glands Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ENDMTRL - Endometrial Cancer Col 125 Usage Notes: Defined as the first occurrence of Endometrial Cancer or a Death due to Endometrial Cancer. Endometrial Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ENDMTRLDY - Days enrollment to Endometrial Cancer Col 126 Days enrollment to Endometrial Cancer
ENDMTRLSRC - Endometrial Cancer ascertainment source Col 127 Usage Notes: Central adjudications were done for Endometrial Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ESOPHAGUS - Esophagus Cancer Col 128 Usage Notes: Defined as the first occurrence of Esophagus Cancer or a Death due to Esophagus Cancer. Esophagus Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ESOPHAGUSDY - Days enrollment to Esophagus Cancer Col 129 Days enrollment to Esophagus Cancer
ESOPHAGUSSRC - Esophagus Cancer ascertainment source Col 130 Usage Notes: Central adjudications were done for Esophagus Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
EYE - Eye and Adnexa Cancer Col 131 Usage Notes: Defined as the first occurrence of Eye and Adnexa Cancer or a Death due to Eye and Adnexa Cancer. Eye and Adnexa Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
EYEDY - Days enrollment to Eye and Adnexa Cancer Col 132 Days enrollment to Eye and Adnexa Cancer
EYESRC - Eye and Adnexa Cancer ascertainment source Col 133 Usage Notes: Central adjudications were done for Eye and Adnexa Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
GALLBLDR - Gallbladder Cancer Col 134 Usage Notes: Defined as the first occurrence of Gallbladder Cancer or a Death due to Gallbladder Cancer. Gallbladder Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
GALLBLDRDY - Days enrollment to Gallbladder Cancer Col 135 Days enrollment to Gallbladder Cancer
GALLBLDRSRC - Gallbladder Cancer ascertainment source Col 136 Usage Notes: Central adjudications were done for Gallbladder Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
GENITAL - Genital Organs Cancer Col 137 Cancer of genital organs, other or unspecified Usage Notes: Defined as the first occurrence of Genital Organs Cancer or a Death due to Genital Organ Cancer. Genital Organs Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
GENITALDY - Days enrollment to Genital Organs Cancer Col 138 Days enrollment to Genital Organs Cancer
GENITALSRC - Genital Organs Cancer ascertainment source Col 139 Usage Notes: Central adjudications were done for Genital Organs Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
GUM - Gum Cancer Col 140 Usage Notes: Defined as the first occurrence of Gum Cancer or a Death due to Gum Cancer . Gum Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
GUMDY - Days enrollment to Gum Cancer Col 141 Days enrollment to Gum Cancer
GUMSRC - Gum Cancer ascertainment source Col 142 Usage Notes: Central adjudications were done for Gum Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
HEART - Heart Cancer Col 143 Usage Notes: Defined as the first occurrence of Heart Cancer or a Death due to Heart Cancer . Heart Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
HEARTDY - Days enrollment to Heart Cancer Col 144 Days enrollment to Heart Cancer
HEARTSRC - Heart Cancer ascertainment source Col 145 Usage Notes: Central adjudications were done for Heart Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
HYPOPHAR - Hypopharynx Cancer Col 146 Usage Notes: Defined as the first occurrence of Hypopharynx Cancer or a Death due to Hypopharynx Cancer. Hypopharynx Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
HYPOPHARDY - Days enrollment to Hypopharynx Cancer Col 147 Days enrollment to Hypopharynx Cancer
HYPOPHARSRC - Hypopharynx Cancer ascertainment source Col 148 Usage Notes: Central adjudications were done for Hypopharynx Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
KIDNEY - Kidney Cancer Col 149 Usage Notes: Defined as the first occurrence of Kidney Cancer or a Death due to Kidney Cancer. Kidney Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
KIDNEYDY - Days enrollment to Kidney Cancer Col 150 Days enrollment to Kidney Cancer
KIDNEYSRC - Kidney Cancer ascertainment source Col 151 Usage Notes: Central adjudications were done for Kidney Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LARYNX - Larynx Cancer Col 152 Usage Notes: Defined as the first occurrence of Larynx Cancer or a Death due to Larynx Cancer. Larynx Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LARYNXDY - Days enrollment to Larynx Cancer Col 153 Days enrollment to Larynx Cancer
LARYNXSRC - Larynx Cancer ascertainment source Col 154 Usage Notes: Central adjudications were done for Larynx Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LEUKEMIA - Leukemia Cancer Col 155 Usage Notes: Defined as the first occurrence of Leukemia Cancer or a Death due to Leukemia. Leukemia Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LEUKEMIADY - Days enrollment to Leukemia Cancer Col 156 Days enrollment to Leukemia Cancer
LEUKEMIASRC - Leukemia Cancer ascertainment source Col 157 Usage Notes: Central adjudications were done for Leukemia Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LIVER - Liver Cancer Col 158 Usage Notes: Defined as the first occurrence of Liver Cancer or a Death due to Liver Cancer. Liver Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LIVERDY - Days enrollment to Liver Cancer Col 159 Days enrollment to Liver Cancer
LIVERSRC - Liver Cancer ascertainment source Col 160 Usage Notes: Central adjudications were done for Liver Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LUNG - Lung Cancer Col 161 Usage Notes: Defined as the first occurrence of Lung Cancer or a Death due to Lung Cancer. Lung Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LUNGDY - Days enrollment to Lung Cancer Col 162 Days enrollment to Lung Cancer
LUNGSRC - Lung Cancer ascertainment source Col 163 Usage Notes: Central adjudications were done for Lung Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LYMPH - Lymph Node Cancer Col 164 Usage Notes: Defined as the first occurrence of Lymph Node Cancer or a Death due to Lymph Node Cancer. Lymph Node Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LYMPHDY - Days enrollment to Lymph Node Cancer Col 165 Days enrollment to Lymph Node Cancer
LYMPHSRC - Lymph Node Cancer ascertainment source Col 166 Usage Notes: Central adjudications were done for Lymph Node Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
HODGKINS - Lymphoma Hodgkins Col 167 Usage Notes: Defined as the first occurrence of Lymphoma Hodgkins or a Death due to Lymphoma, Hodgkins. Lymphoma Hodgkins is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
HODGKINSDY - Days enrollment to Lymphoma Hodgkins Col 168 Days enrollment to Lymphoma Hodgkins
HODGKINSSRC - Lymphoma Hodgkins ascertainment source Col 169 Usage Notes: Central adjudications were done for Lymphoma Hodgkins. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LYMPHOMA - Lymphoma Non Hodgkins Col 170 Usage Notes: Defined as the first occurrence of Lymphoma Non Hodgkins or a Death due to Lymphoma (NHL only). Lymphoma Non Hodgkins is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
LYMPHOMADY - Days enrollment to Lymphoma Non Hodgkins Col 171 Days enrollment to Lymphoma Non Hodgkins
LYMPHOMASRC - Lymphoma Non Hodgkins ascertainment source Col 172 Usage Notes: Central adjudications were done for Lymphoma Non Hodgkins. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MELANOMA - Melanoma of the Skin Col 173 Usage Notes: Defined as the first occurrence of Melanoma of the Skin or a Death due to Melanoma. Melanoma of the Skin is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MELANOMADY - Days enrollment to Melanoma of the Skin Col 174 Days enrollment to Melanoma of the Skin
MELANOMASRC - Melanoma of the Skin ascertainment source Col 175 Usage Notes: Central adjudications were done for Melanoma of the Skin. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MENINGES - Meninges Cancer Col 176 Usage Notes: Defined as the first occurrence of Meninges Cancer or a Death due to Meninges Cancer. Meninges Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MENINGESDY - Days enrollment to Meninges Cancer Col 177 Days enrollment to Meninges Cancer
MENINGESSRC - Meninges Cancer ascertainment source Col 178 Usage Notes: Central adjudications were done for Meninges Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MMYELOMA - Multiple Myeloma Col 179 Usage Notes: Defined as the first occurrence of Multiple Myeloma or a Death due to Multiple Myeloma. Multiple Myeloma is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MMYELOMADY - Days enrollment to Multiple Myeloma Col 180 Days enrollment to Multiple Myeloma
MMYELOMASRC - Multiple Myeloma ascertainment source Col 181 Usage Notes: Central adjudications were done for Multiple Myeloma. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MOUTHFLOOR - Floor Of Mouth Cancer Col 182 Usage Notes: Defined as the first occurrence of Floor Of Mouth Cancer or a Death due to Floor Of Mouth Cancer. Floor Of Mouth Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MOUTHFLOORDY - Days enrollment to Floor Of Mouth Cancer Col 183 Days enrollment to Floor Of Mouth Cancer
MOUTHFLOORSRC - Floor Of Mouth Cancer ascertainment source Col 184 Usage Notes: Central adjudications were done for Floor Of Mouth Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MYCOSISF - Mycosis Fungoides Col 185 Usage Notes: Defined as the first occurrence of Mycosis Fungoides or a Death due to Mycosis Fungoidies. Mycosis Fungoides is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
MYCOSISFDY - Days enrollment to Mycosis Fungoides Col 186 Days enrollment to Mycosis Fungoides
MYCOSISFSRC - Mycosis Fungoides ascertainment source Col 187 Usage Notes: Central adjudications were done for Mycosis Fungoides. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
NASAL - Nasal Cavity Mid Ear Cancer Col 188 Usage Notes: Defined as the first occurrence of Nasal Cavity Mid Ear Cancer or a Death due to Nasal Cavity Mid Ear Cancer. Nasal Cavity Mid Ear Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
NASALDY - Days enrollment to Nasal Cavity Mid Ear Cancer Col 189 Days enrollment to Nasal Cavity Mid Ear Cancer
NASALSRC - Nasal Cavity Mid Ear Cancer ascertainment source Col 190 Usage Notes: Central adjudications were done for Nasal Cavity Mid Ear Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
NASOPHAR - Nasopharynx Cancer Col 191 Usage Notes: Defined as the first occurrence of Nasopharynx Cancer or a Death due to Nasopharynx Cancer. Nasopharynx Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
NASOPHARDY - Days enrollment to Nasopharynx Cancer Col 192 Days enrollment to Nasopharynx Cancer
NASOPHARSRC - Nasopharynx Cancer ascertainment source Col 193 Usage Notes: Central adjudications were done for Nasopharynx Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ORALUNSP - Oral (Mouth) Cancer Col 194 Oral cancer, mouth, other or unspecified Usage Notes: Defined as the first occurrence of Oral (Mouth) Cancer or a Death due to Oral (Mouth) Cancer. Oral (Mouth) Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ORALUNSPDY - Days enrollment to Oral (Mouth) Cancer Col 195 Days enrollment to Oral (Mouth) Cancer
ORALUNSPSRC - Oral (Mouth) Cancer ascertainment source Col 196 Usage Notes: Central adjudications were done for Oral (Mouth) Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
OROPHARYNX - Oropharynx Cancer Col 197 Usage Notes: Defined as the first occurrence of Oropharynx Cancer or a Death due to Oropharynx Cancer. Oropharynx Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
OROPHARYNXDY - Days enrollment to Oropharynx Cancer Col 198 Days enrollment to Oropharynx Cancer
OROPHARYNXSRC - Oropharynx Cancer ascertainment source Col 199 Usage Notes: Central adjudications were done for Oropharynx Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
OTHERDIGEST - Other Digestive Cancer Col 200 Usage Notes: Defined as the first occurrence of Other Digestive Cancer or a Death due to Other Digestive Cancer. Other Digestive Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
OTHERDIGESTDY - Days enrollment to Other Digestive Cancer Col 201 Days enrollment to Other Digestive Cancer
OTHERDIGESTSRC - Other Digestive Cancer ascertainment source Col 202 Usage Notes: Central adjudications were done for Other Digestive Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
OTHERLIP - Other Lip Cancer Col 203 Usage Notes: Defined as the first occurrence of Other Lip Cancer or a Death due to Other Lip Cancer. Other Lip Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
OTHERLIPDY - Days enrollment to Other Lip Cancer Col 204 Days enrollment to Other Lip Cancer
OTHERLIPSRC - Other Lip Cancer ascertainment source Col 205 Usage Notes: Central adjudications were done for Other Lip Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
OVARY - Ovarian Cancer Col 206 Usage Notes: Defined as the first occurrence of Ovarian Cancer or a Death due to Ovarian Cancer. Ovarian Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
OVARYDY - Days enrollment to Ovarian Cancer Col 207 Days enrollment to Ovarian Cancer
OVARYSRC - Ovarian Cancer ascertainment source Col 208 Usage Notes: Central adjudications were done for Ovarian Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PALATE - Palate Cancer Col 209 Usage Notes: Defined as the first occurrence of Palate Cancer or a Death due to Palate Cancer. Palate Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PALATEDY - Days enrollment to Palate Cancer Col 210 Days enrollment to Palate Cancer
PALATESRC - Palate Cancer ascertainment source Col 211 Usage Notes: Central adjudications were done for Palate Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PANCREAS - Pancreas Cancer Col 212 Usage Notes: Defined as the first occurrence of Pancreas Cancer or a Death due to Pancreas. Pancreas Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PANCREASDY - Days enrollment to Pancreas Cancer Col 213 Days enrollment to Pancreas Cancer
PANCREASSRC - Pancreas Cancer ascertainment source Col 214 Usage Notes: Central adjudications were done for Pancreas Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PAROTID - Parotid Gland,Stensens Cancer Col 215 Cancer of Parotid gland or Stensens duct Usage Notes: Defined as the first occurrence of Parotid Gland,Stensens Cancer or a Death due to Parotid Gland,Stensens Cancer. Parotid Gland,Stensens Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PAROTIDDY - Days enrollment to Parotid Gland,Stensens Cancer Col 216 Days enrollment to Parotid Gland,Stensens Cancer
PAROTIDSRC - Parotid Gland,Stensens Cancer ascertainment source Col 217 Usage Notes: Central adjudications were done for Parotid Gland,Stensens Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PERIPHERAL - Peripheral Nerves Cancer Col 218 Cancer of Peripheral nerves and autonomic system Usage Notes: Defined as the first occurrence of Peripheral Nerves Cancer or a Death due to Peripheral Nerves Cancer. Peripheral Nerves Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PERIPHERALDY - Days enrollment to Peripheral Nerves Cancer Col 219 Days enrollment to Peripheral Nerves Cancer
PERIPHERALSRC - Peripheral Nerves Cancer ascertainment source Col 220 Usage Notes: Central adjudications were done for Peripheral Nerves Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PERITONEUM - Peritoneum Cancer Col 221 Usage Notes: Defined as the first occurrence of Peritoneum Cancer or a Death due to Peritoneum Cancer. Peritoneum Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PERITONEUMDY - Days enrollment to Peritoneum Cancer Col 222 Days enrollment to Peritoneum Cancer
PERITONEUMSRC - Peritoneum Cancer ascertainment source Col 223 Usage Notes: Central adjudications were done for Peritoneum Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PYRIFORM - Pyriform Sinus Cancer Col 224 Usage Notes: Defined as the first occurrence of Pyriform Sinus Cancer or a Death due to Pyriform Sinus Cancer. Pyriform Sinus Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
PYRIFORMDY - Days enrollment to Pyriform Sinus Cancer Col 225 Days enrollment to Pyriform Sinus Cancer
PYRIFORMSRC - Pyriform Sinus Cancer ascertainment source Col 226 Usage Notes: Central adjudications were done for Pyriform Sinus Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
RECTOSIG - Rectosigmoid Cancer Col 227 Cancer of the rectosigmoid junction Usage Notes: Defined as the first occurrence of Rectosigmoid Cancer or a Death due to Rectosigmoid Cancer. Rectosigmoid Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
RECTOSIGDY - Days enrollment to Rectosigmoid Cancer Col 228 Days enrollment to Rectosigmoid Cancer
RECTOSIGSRC - Rectosigmoid Cancer ascertainment source Col 229 Usage Notes: Central adjudications were done for Rectosigmoid Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
RECTUM - Rectum Cancer Col 230 Usage Notes: Defined as the first occurrence of Rectum Cancer or a Death due to Rectum Cancer. Rectum Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
RECTUMDY - Days enrollment to Rectum Cancer Col 231 Days enrollment to Rectum Cancer
RECTUMSRC - Rectum Cancer ascertainment source Col 232 Usage Notes: Central adjudications were done for Rectum Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
RENALPELV - Renal Pelvis Cancer Col 233 Usage Notes: Defined as the first occurrence of Renal Pelvis Cancer or a Death due to Renal Pelvis Cancer. Renal Pelvis Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
RENALPELVDY - Days enrollment to Renal Pelvis Cancer Col 234 Days enrollment to Renal Pelvis Cancer
RENALPELVSRC - Renal Pelvis Cancer ascertainment source Col 235 Usage Notes: Central adjudications were done for Renal Pelvis Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
RESP - Respiratory Cancer Col 236 Cancer of respiratory system and intrathoracic. Usage Notes: Defined as the first occurrence of Respiratory Cancer or a Death due to Respiratory Cancer. Respiratory Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
RESPDY - Days enrollment to Respiratory Cancer Col 237 Days enrollment to Respiratory Cancer
RESPSRC - Respiratory Cancer ascertainment source Col 238 Usage Notes: Central adjudications were done for Respiratory Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
SALIVARY - Salivary Glands Cancer Col 239 Cancer of salivary glands, major, other or unspecified. Usage Notes: Defined as the first occurrence of Salivary Glands Cancer or a Death due to Salivary Glands Cancer. Salivary Glands Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
SALIVARYDY - Days enrollment to Salivary Glands Cancer Col 240 Days enrollment to Salivary Glands Cancer
SALIVARYSRC - Salivary Glands Cancer ascertainment source Col 241 Usage Notes: Central adjudications were done for Salivary Glands Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
SMINTEST - Small Intestine Cancer Col 242 Usage Notes: Defined as the first occurrence of Small Intestine Cancer or a Death due to Small Intestine Cancer. Small Intestine Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
SMINTESTDY - Days enrollment to Small Intestine Cancer Col 243 Days enrollment to Small Intestine Cancer
SMINTESTSRC - Small Intestine Cancer ascertainment source Col 244 Usage Notes: Central adjudications were done for Small Intestine Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
STOMACH - Stomach Cancer Col 245 Usage Notes: Defined as the first occurrence of Stomach Cancer or a Death due to Stomach Cancer. Stomach Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
STOMACHDY - Days enrollment to Stomach Cancer Col 246 Days enrollment to Stomach Cancer
STOMACHSRC - Stomach Cancer ascertainment source Col 247 Usage Notes: Central adjudications were done for Stomach Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
THYMUS - Thymus Cancer Col 248 Usage Notes: Defined as the first occurrence of Thymus Cancer or a Death due to Thymus Cancer . Thymus Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
THYMUSDY - Days enrollment to Thymus Cancer Col 249 Days enrollment to Thymus Cancer
THYMUSSRC - Thymus Cancer ascertainment source Col 250 Usage Notes: Central adjudications were done for Thymus Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
THYROID - Thyroid Cancer Col 251 Usage Notes: Defined as the first occurrence of Thyroid Cancer or a Death due to Thyroid Cancer. Thyroid Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
THYROIDDY - Days enrollment to Thyroid Cancer Col 252 Days enrollment to Thyroid Cancer
THYROIDSRC - Thyroid Cancer ascertainment source Col 253 Usage Notes: Central adjudications were done for Thyroid Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
TONGUE - Tongue Cancer Col 254 Cancer of tongue, other or unspecified part Usage Notes: Defined as the first occurrence of Tongue Cancer or a Death due to Tongue Cancer. Tongue Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
TONGUEDY - Days enrollment to Tongue Cancer Col 255 Days enrollment to Tongue Cancer
TONGUESRC - Tongue Cancer ascertainment source Col 256 Usage Notes: Central adjudications were done for Tongue Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
TONSIL - Tonsil Cancer Col 257 Usage Notes: Defined as the first occurrence of Tonsil Cancer or a Death due to Tonsil Cancer. Tonsil Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
TONSILDY - Days enrollment to Tonsil Cancer Col 258 Days enrollment to Tonsil Cancer
TONSILSRC - Tonsil Cancer ascertainment source Col 259 Usage Notes: Central adjudications were done for Tonsil Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
TRACHEA - Trachea Cancer Col 260 Usage Notes: Defined as the first occurrence of Trachea Cancer or a Death due to Trachea Cancer. Trachea Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
TRACHEADY - Days enrollment to Trachea Cancer Col 261 Days enrollment to Trachea Cancer
TRACHEASRC - Trachea Cancer ascertainment source Col 262 Usage Notes: Central adjudications were done for Trachea Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
URETER - Ureter Cancer Col 263 Usage Notes: Defined as the first occurrence of Ureter Cancer or a Death due to Ureter Cancer. Ureter Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
URETERDY - Days enrollment to Ureter Cancer Col 264 Days enrollment to Ureter Cancer
URETERSRC - Ureter Cancer ascertainment source Col 265 Usage Notes: Central adjudications were done for Ureter Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
URINARY - Urinary Organs Cancer Col 266 Cancer of urinary organs, other or unspecified. Usage Notes: Defined as the first occurrence of Urinary Organs Cancer or a Death due to Urinary Organs Cancer. Urinary Organs Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
URINARYDY - Days enrollment to Urinary Organs Cancer Col 267 Days enrollment to Urinary Organs Cancer
URINARYSRC - Urinary Organs Cancer ascertainment source Col 268 Usage Notes: Central adjudications were done for Urinary Organs Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
UTERINE - Uterus, Not Spec. Cancer Col 269 Cancer of uterus, not otherwise specified Usage Notes: Defined as the first occurrence of Uterus, Not Spec. Cancer or a Death due to Uterine Cancer. Uterus, Not Spec. Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
UTERINEDY - Days enrollment to Uterus, Not Spec. Cancer Col 270 Days enrollment to Uterus, Not Spec. Cancer
UTERINESRC - Uterus, Not Spec. Cancer ascertainment source Col 271 Usage Notes: Central adjudications were done for Uterus, Not Spec. Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
VAGINA - Vagina Cancer Col 272 Usage Notes: Defined as the first occurrence of Vagina Cancer or a Death due to Vagina Cancer. Vagina Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
VAGINADY - Days enrollment to Vagina Cancer Col 273 Days enrollment to Vagina Cancer
VAGINASRC - Vagina Cancer ascertainment source Col 274 Usage Notes: Central adjudications were done for Vagina Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
VULVA - Vulva Cancer Col 275 Usage Notes: Defined as the first occurrence of Vulva Cancer or a Death due to Vulva Cancer. Vulva Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
VULVADY - Days enrollment to Vulva Cancer Col 276 Days enrollment to Vulva Cancer
VULVASRC - Vulva Cancer ascertainment source Col 277 Usage Notes: Central adjudications were done for Vulva Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
CANCOTHER - Other/Unknown Cancer Col 278 Usage Notes: Defined as an occurrence of any cancer site not listed above. Other/Unknown Cancer is adjudicated for CT and OS participants. See the DEATH and DEATHSRC variables for details about the death adjudication process.
CANCOTHERDY - Days enrollment to Other/Unknown Cancer Col 279 Days enrollment to Other/Unknown Cancer
CANCOTHERSRC - Other/Unknown Cancer ascertainment source Col 280 Usage Notes: Central adjudications were done for Other/Unknown Cancer. If the central adjudication is not complete, local adjudication data is used. See the DEATH and DEATHSRC variables for details about the death adjudication process.
ANYFX - Any Adjudicated Fracture Col 281 Usage Notes: Defined as the first fracture of Hip, upper leg, pelvis, knee, lower leg, ankle, foot(not toe), tailbone, spine or back, lower arm or wrist, hand (not finger), elbow, upper arm or shoulder and other. These outcomes have different adjudication rules. See the individual outcomes for details.
ANYFXDY - Days enrollment to Any Adjudicated Fracture Col 282 Days enrollment to Any Adjudicated Fracture
ANYFXSRC - Any Adjudicated Fracture ascertainment source Col 283 Usage Notes: The ascertainment processes vary for these outcomes. Refer to their usage notes.
BKANKLE - Ankle Fracture Col 284 Usage Notes: Ankle Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Ankle Fracture is not counted if pathologic.
BKANKLEDY - Days enrollment to Ankle Fracture Col 285 Days enrollment to Ankle Fracture
BKANKLESRC - Ankle Fracture ascertainment source Col 286 Usage Notes: Ankle Fracture was only adjudicated locally.
BKCARPAL - Carpal Fracture Col 287 Carpal bones in wrist Usage Notes: Carpal Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Carpal Fracture is not counted if pathologic.
BKCARPALDY - Days enrollment to Carpal Fracture Col 288 Days enrollment to Carpal Fracture
BKCARPALSRC - Carpal Fracture ascertainment source Col 289 Usage Notes: Carpal Fracture was only adjudicated locally.
BKCLAVICLE - Clavical Fracture Col 290 Usage Notes: Clavical Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Clavical Fracture is not counted if pathologic.
BKCLAVICLEDY - Days enrollment to Clavical Fracture Col 291 Days enrollment to Clavical Fracture
BKCLAVICLESRC - Clavical Fracture ascertainment source Col 292 Usage Notes: Clavical Fracture was only adjudicated locally.
BKELBOWNOS - Elbow NOS Fracture Col 293 Elbow, not otherwise specified Usage Notes: Elbow NOS Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Elbow NOS Fracture is not counted if pathologic.
BKELBOWNOSDY - Days enrollment to Elbow NOS Fracture Col 294 Days enrollment to Elbow NOS Fracture
BKELBOWNOSSRC - Elbow NOS Fracture ascertainment source Col 295 Usage Notes: Elbow NOS Fracture was only adjudicated locally.
BKHIP - Hip Fracture Col 296 Usage Notes: Hip Fracture was adjudicated for CT and OS participants through Ext1. In Ext2 it is only adjudicated for the Medical Record Cohort.
BKHIPDY - Days enrollment to Hip Fracture Col 297 Days enrollment to Hip Fracture
BKHIPSRC - Hip Fracture ascertainment source Col 298 Usage Notes: Central adjudications were done for Hip Fracture. If the central adjudication is not complete, local adjudication data is used.
BKLELBOW - Lower End of Humerus Fracture Col 299 Usage Notes: Lower End of Humerus Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Lower End of Humerus Fracture is not counted if pathologic.
BKLELBOWDY - Days enrollment to Lower End of Humerus Fracture Col 300 Days enrollment to Lower End of Humerus Fracture
BKLELBOWSRC - Lower End of Humerus Fracture ascertainment source Col 301 Usage Notes: Lower End of Humerus Fracture was only adjudicated locally.
BKHAND - Metacarpal Fracture Col 302 Usage Notes: Metacarpal Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Metacarpal Fracture is not counted if pathologic.
BKHANDDY - Days enrollment to Metacarpal Fracture Col 303 Days enrollment to Metacarpal Fracture
BKHANDSRC - Metacarpal Fracture ascertainment source Col 304 Usage Notes: Metacarpal Fracture was only adjudicated locally.
BKPATELLA - Patella Fracture Col 305 Usage Notes: Patella Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Patella Fracture is not counted if pathologic.
BKPATELLADY - Days enrollment to Patella Fracture Col 306 Days enrollment to Patella Fracture
BKPATELLASRC - Patella Fracture ascertainment source Col 307 Usage Notes: Patella Fracture was only adjudicated locally.
BKPELVIS - Pelvis Fracture Col 308 Usage Notes: Pelvis Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Pelvis Fracture is not counted if pathologic.
BKPELVISDY - Days enrollment to Pelvis Fracture Col 309 Days enrollment to Pelvis Fracture
BKPELVISSRC - Pelvis Fracture ascertainment source Col 310 Usage Notes: Pelvis Fracture was only adjudicated locally.
BKLARM - Radius or Ulna Fracture Col 311 Usage Notes: Radius or Ulna Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Radius or Ulna Fracture is not counted if pathologic.
BKLARMDY - Days enrollment to Radius or Ulna Fracture Col 312 Days enrollment to Radius or Ulna Fracture
BKLARMSRC - Radius or Ulna Fracture ascertainment source Col 313 Usage Notes: Radius or Ulna Fracture was only adjudicated locally.
BKCOCCYX - Sacrum or Coccyx Fracture Col 314 Usage Notes: Sacrum or Coccyx Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Sacrum or Coccyx Fracture is not counted if pathologic.
BKCOCCYXDY - Days enrollment to Sacrum or Coccyx Fracture Col 315 Days enrollment to Sacrum or Coccyx Fracture
BKCOCCYXSRC - Sacrum or Coccyx Fracture ascertainment source Col 316 Usage Notes: Sacrum or Coccyx Fracture was only adjudicated locally.
BKSCAPULA - Scapula Fracture Col 317 Usage Notes: Scapula Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Scapula Fracture is not counted if pathologic.
BKSCAPULADY - Days enrollment to Scapula Fracture Col 318 Days enrollment to Scapula Fracture
BKSCAPULASRC - Scapula Fracture ascertainment source Col 319 Usage Notes: Scapula Fracture was only adjudicated locally.
BKUPPERLEG - Shaft of Femur Fracture Col 320 Usage Notes: Shaft of Femur Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Shaft of Femur Fracture is not counted if pathologic.
BKUPPERLEGDY - Days enrollment to Shaft of Femur Fracture Col 321 Days enrollment to Shaft of Femur Fracture
BKUPPERLEGSRC - Shaft of Femur Fracture ascertainment source Col 322 Usage Notes: Shaft of Femur Fracture was only adjudicated locally.
BKOHUMERUS - Shaft of Humerus Fracture Col 323 Fracture of humerus, shaft or unspecified part Usage Notes: Shaft of Humerus Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Shaft of Humerus Fracture is not counted if pathologic.
BKOHUMERUSDY - Days enrollment to Shaft of Humerus Fracture Col 324 Days enrollment to Shaft of Humerus Fracture
BKOHUMERUSSRC - Shaft of Humerus Fracture ascertainment source Col 325 Usage Notes: Shaft of Humerus Fracture was only adjudicated locally.
BKFOOT - Tarsal or Metatarsal Fracture Col 326 Usage Notes: Tarsal or Metatarsal Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Tarsal or Metatarsal Fracture is not counted if pathologic.
BKFOOTDY - Days enrollment to Tarsal or Metatarsal Fracture Col 327 Days enrollment to Tarsal or Metatarsal Fracture
BKFOOTSRC - Tarsal or Metatarsal Fracture ascertainment source Col 328 Usage Notes: Tarsal or Metatarsal Fracture was only adjudicated locally.
BKTIBIAFIBULA - Tibia or Fibula Fracture Col 329 Usage Notes: Tibia or Fibula Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Tibia or Fibula Fracture is not counted if pathologic.
BKTIBIAFIBULADY - Days enrollment to Tibia or Fibula Fracture Col 330 Days enrollment to Tibia or Fibula Fracture
BKTIBIAFIBULASRC - Tibia or Fibula Fracture ascertainment source Col 331 Usage Notes: Tibia or Fibula Fracture was only adjudicated locally.
BKTIBIAL - Tibial Plateau Fracture Col 332 Usage Notes: Tibial Plateau Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Tibial Plateau Fracture is not counted if pathologic.
BKTIBIALDY - Days enrollment to Tibial Plateau Fracture Col 333 Days enrollment to Tibial Plateau Fracture
BKTIBIALSRC - Tibial Plateau Fracture ascertainment source Col 334 Usage Notes: Tibial Plateau Fracture was only adjudicated locally.
BKUHUMERUS - Upper End of Humerus Fracture Col 335 Usage Notes: Upper End of Humerus Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Upper End of Humerus Fracture is not counted if pathologic.
BKUHUMERUSDY - Days enrollment to Upper End of Humerus Fracture Col 336 Days enrollment to Upper End of Humerus Fracture
BKUHUMERUSSRC - Upper End of Humerus Fracture ascertainment source Col 337 Usage Notes: Upper End of Humerus Fracture was only adjudicated locally.
BKUELBOW - Upper Radius/Ulna Fracture Col 338 Usage Notes: Upper Radius/Ulna Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Upper Radius/Ulna Fracture is not counted if pathologic.
BKUELBOWDY - Days enrollment to Upper Radius/Ulna Fracture Col 339 Days enrollment to Upper Radius/Ulna Fracture
BKUELBOWSRC - Upper Radius/Ulna Fracture ascertainment source Col 340 Usage Notes: Upper Radius/Ulna Fracture was only adjudicated locally.
BKSPINE - Vertebral Fracture Col 341 Usage Notes: Defined as the first occurrence of Lumbar Spine Fracture or Thoracic Spine Fracture. Vertebral Fracture was adjudicated during the core WHI study. They are adjudicated at all clinics for CT participants, but only adjudicated at the bone density clinics for OS participants. Does not include cervical fractures.
BKSPINEDY - Days enrollment to Vertebral Fracture Col 342 Days enrollment to Vertebral Fracture
BKSPINESRC - Vertebral Fracture ascertainment source Col 343 Usage Notes: Vertebral Fracture was only adjudicated locally.
DEATH - Death Col 344 Did the participant die during a consented study phase? Usage Notes: Death was adjudicated for CT and OS participants through Ext1. In Ext2, death is only adjudicated for the Medical Record Cohort (MRC). Non MRC cause of death is determined by the initial cause of death form (form 120). See the DEATHSRC variable for details about the death adjudication process. This variable censors deaths that occur after the participant's last consented study phase, e.g. if a ppt did not consent to Ext2, but we discovered that she died during Ext2 DEATH would have a value of 0. This is done because the discovery rate of death is inconsistent after participant followup ends. See the DEATHALL variable in the All Discovered Death Outcome Detail file to see all discovered deaths.
DEATHCAUSE - Cause of Death Col 345 Usage Notes: "Unknown cause (Not yet adj)" (code 100) are reported deaths where the adjudication is in process. In Ext2 only MRC deaths are adjudicated. Non MRC cause of death is determined by the initial cause of death form (form 120). The cause of death values on form 120 are a subset of the causes of death that can be determined from a form 124. If the form 124 was marked Other or Unknown cause of death the ICD code was used to determine cause of death (see the UNDRICD variable in the death detail file). A cross tabulation of DEATHCAUSE with UNDRICD should be examined to ascertain which ICD codes are included in each DEATHCAUSE category.
DEATHDY - Days enrollment to Death Col 346 Days enrollment to Death
DEATHSRC - Death ascertainment source Col 347 Usage Notes: During the core WHI study, central adjudications of Death were only done in the CT. In Ext1 deaths were centrally adjudicated for all participants. In Ext2, death is only adjudicated for the Medical Record Cohort (MRC). Non MRC cause of death is determined by the initial cause of death form (form 120).
DEATHCAUSESRC - Cause of Death ascertainment source Col 348 Usage Notes: Cause of death is usually determined from the form 124 underlying cause of death subclass question. If this question is answered other/unknown and has an ICD code, the cause of death will be determined from the ICD code. In the case of an Ext2 SRC death, the cause of death comes from the form 120 subclass question.
HYST - Hysterectomy Col 349 Usage Notes: Hysterectomy was adjudicated for HT participants only. It was not adjudicated after Ext1.
HYSTDY - Days enrollment to Hysterectomy Col 350 Days enrollment to Hysterectomy
HYSTSRC - Hysterectomy ascertainment source Col 351 Usage Notes: Hysterectomy was only adjudicated locally.
ENDWHIDY - Days enrollment to end of WHI core study followup Col 352 Usage Notes: ENDWHIDY should only be used for analyses censoring follow-up at the end of the WHI core study.
ENDEXT1DY - Days enrollment to end of Ext1 followup Col 353 Usage Notes: ENDEXT1DY should only be used for analyses censoring follow-up at the end of Ext1.
ENDFOLLOWDY - Days enrollment to end of followup Col 354 Usage Notes: ENDFOLLOWDY represents the days from enrollment to death if it occurred, or end of follow-up. ENDFOLLOWDY should be used for non-cancer outcomes in analyses utilizing all WHI, Ext1 and Ext2 follow-up. Any analyses of cancer outcomes utilizing all WHI, Ext1 and Ext2 follow-up time should use the ENDCANCERDY variable to determine time of last follow-up for non-events.
ENDCANCERDY - Days enrollment to end of cancer followup Col 355 Usage Notes: WHI is currently shifting to use of the NCI Virtual Pooled Registry (VPR) for cancer data. As of June 15, 2023, WHI has stopped adjudicating cancers for the SRC participants that are covered by the registry. The cancer data in this file only includes those adjudications that WHI has performed. VPR cancer data compilation and QA is currently underway and access to this data will be at a future date. ENDCANCERDY represents the days from enrollment to death if it occurred, or end of follow-up, based on the overall time in which cancer has been followed for each participant (this follow-up time varies from the total follow-up time captured in ENDFOLLOWDY). ENDCANCERDY should be used in analyses of cancer outcomes utilizing all WHI, Ext1, and Ext2 follow-up time to determine time of last follow-up for non-events.
|
In Ext2 cancer outcomes are adjudicated for all ppts, other outcomes are only adjudicated for Medical Record Cohort (MRC) ppts. see Outcomes Summary Tables